SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor–deficient mice

  1. Geoffrey J. Lindeman1,
  2. Sergio Wittlin1,
  3. Hania Lada1,
  4. Matthew J. Naylor3,
  5. Margaret Santamaria1,
  6. Jian-Guo Zhang1,2,
  7. Robyn Starr1,2,
  8. Douglas J. Hilton1,2,
  9. Warren S. Alexander1,2,
  10. Christopher J. Ormandy3, and
  11. Jane Visvader1,4
  1. 1The Walter and Eliza Hall Institute of Medical Research, Bone Marrow Research Laboratories, and 2Cooperative Research Centre for Cellular Growth Factors, PO Royal Melbourne Hospital, VIC 3050, Australia; 3Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia

Abstract

Prolactin is essential for proliferation and differentiation of the developing mammary gland. We have explored a role for Suppressor of Cytokine Signaling 1 (SOCS1) as a modulator of the prolactin response using mice deficient in SOCS1, which were rescued from neonatal death by deletion of the Interferon gamma (IFNγ) gene. SOCS1−/−/IFNγ−/− mice exhibited accelerated lobuloalveolar development in the mammary gland during late pregnancy and precocious lactation. Significantly, the lactogenic defect in prolactin receptor heterozygous females could be rescued by deletion of a single SOCS1 allele. These findings establish a role for SOCS1 as a negative regulator of prolactin signaling and suggest that SOCS1 is required for the prevention of lactation prior to parturition.

Keywords

Footnotes

  • 4 Corresponding author.

  • E-MAIL visvader{at}wehi.edu.au; FAX 61-3-9342-8634.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.880801.

    • Received January 18, 2001.
    • Accepted May 5, 2001.
| Table of Contents

Life Science Alliance